Skip to main content

Table 1 Characteristics of clinical isolates used in this study

From: Biofilm formation by clinical isolates and the implications in chronic infections

Bacterial species

Clinical isolates

# of patients

Pulsed- Field Type (PFTs)

*Phenotype

Site of isolation

E. coli

39

32

1 (n=4)

ESBL+ (n=31)

Wound culture (n=10)

   

2 (n=5)

 

Blood (n=4)

   

3 (n=3)

 

Urine (n=21)

   

4 (n=7)

  
   

7 (n=5)

  
   

Other (n=15)

  

K. pneumoniae

54

33

1 (n=6)

MDR (n=54)

Wound culture (n=39)

   

2 (n=8)

 

Blood (n=10)

   

3,4,14,16,17, 18 (n=5)

 

Respiratory (n=5)

   

Other (n=10)

  

P. aeruginosa

36

17

1 (n=7)

MDR (n=28)

Wound culture (n=29)

   

2, 18 (n=5)

 

Blood (n=7)

   

Other (n=19)

  

A. baumannii

53

47

1 (n=13)

MDR (n=46)

Wound culture (n=31)

   

5 (n=4)

 

Blood (n=20)

2,3,4, 6,7,14 (n=5)

 

Urine (n=1)

   

Other (n=6)

 

Respiratory (n=1)

S. aureus

23

21

USA100 (n=10)

MRSA (n=15)

Wound culture (n=14)

   

USA200, USA800 (n=4)

MSSA (n=8)

Blood (n=4)

   

USA300 (n=2)

 

Respiratory (n=5)

   

USA700 (n=3)

  
  1. *A multidrug-resistant (MDR) organism was defined as any extended spectrum beta-lactamase (ESBL)-producing bacteria, or if resistant to all tested antimicrobials in 3 or more classes of antimicrobial agents (penicillins/cephalosporins, carbapenems, aminoglycosides, and quinolones) not including tetracyclines or colistin.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us